# Boehringer Ingelheim (Austria)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/boehringer-ingelheim-austria/

## Facts

| Field | Value |
| --- | --- |
| Citations | 292,183 |
| City | Vienna |
| Country | AT |
| Description | Boehringer Ingelheim (Austria) is a research organisation in Vienna, AT. OpenAlex records 1,402 works and 292,183 citations for it. 533 researchers list it as their most recent affiliation. |
| Homepage | https://www.boehringer-ingelheim.at/en |
| OpenAlex ID | https://openalex.org/I4210119669 |
| Researchers | 533 |
| ROR ID | https://ror.org/026vtvm28 |
| Type | company |
| Works | 1,402 |

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Viral Infectious Diseases and Gene Expression in Insects](https://scholariq.org/topics/viral-infectious-diseases-and-gene-expression-in-insects/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.